Marinus pharmaceuticals articles
-
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medi
-
Deciphera to be acquired by Ono Pharmaceutical for $2.4 billion
Ono Pharmaceutical will pay $25.60 per Deciphera share in cash, a premium of nearly 75 percent on the Waltham cancer biotech’s closing price of $14.65 on Friday.
-
EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 6.6%
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report)’s share price traded down 6.6% on Wednesday . The stock traded as low as $16.35 and last traded at $16.41. 183,520 shares changed hands during mid-day trading, a decline of 81% from the average session volume of 988,294 shares. The stock had previously closed at $17.57. Analyst […]